CN114796371A - 一种用于治疗糖尿病并发症的药物 - Google Patents
一种用于治疗糖尿病并发症的药物 Download PDFInfo
- Publication number
- CN114796371A CN114796371A CN202210483191.6A CN202210483191A CN114796371A CN 114796371 A CN114796371 A CN 114796371A CN 202210483191 A CN202210483191 A CN 202210483191A CN 114796371 A CN114796371 A CN 114796371A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- blood
- ginseng
- pseudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 208000002249 Diabetes Complications Diseases 0.000 title claims abstract description 14
- 206010012655 Diabetic complications Diseases 0.000 title claims abstract description 14
- 229940079593 drug Drugs 0.000 title description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 19
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 19
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 19
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 19
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 19
- 239000009136 dragon's blood Substances 0.000 claims abstract description 19
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract description 18
- 238000002791 soaking Methods 0.000 claims abstract description 14
- 241000218691 Cupressaceae Species 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000000645 desinfectant Substances 0.000 claims description 5
- 230000000249 desinfective effect Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000972672 Phellodendron Species 0.000 claims description 2
- 208000008960 Diabetic foot Diseases 0.000 abstract description 10
- 206010053615 Thermal burn Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000004044 response Effects 0.000 abstract description 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000001804 debridement Methods 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种用于治疗糖尿病并发症的药物,本发明所提供的药物配方设计合理,通过将野兔毛浸泡于血竭、三七、地榆、黄柏的浸泡液中,可制得所述药物;所制备的药物为敷料,使用方法为外敷,使用方便,且无任何毒副作用,所述药物适用于糖尿病足,老烂腿,褥疮,烫伤等病症,其疗效显著,见效较快。
Description
技术领域
本发明涉及治疗糖尿病药物技术领域,具体是指一种用于治疗糖尿病并发症的药物。
背景技术
糖尿病是一组由于胰岛素分泌缺陷或胰岛素作用障碍所致的以高血糖为特征的代谢性疾病。持续高血糖与长期代谢紊乱等可导致全身组织器官,特别是眼、肾、心血管及神经系统的损害及其功能障碍和衰竭。严重者可引起失水,电解质紊乱和酸碱平衡失调等急性并发症酮症酸中毒和高渗昏迷;
糖尿病足约占糖尿病患者的15%,其中糖尿病足的截肢率是非糖尿病足患者的17倍左右,由于糖尿病足患者一般是年龄偏大、血压偏高、糖化红蛋白高、红细胞携氧能力差、血液粘度高、血管硬化变脆增厚、细胞变形能力下降,下肢动脉搏动降低、周围微细血管出现血栓或者形成斑点阻塞血管,造成患者供血供氧不足、营养不良、代谢紊乱等;
中医称糖尿病为消渴病,即肺、脾、肾三脏之病,患者多表现为多饮、多食、多尿、疲乏、失眠、下肢干燥、走路跛行、趾部容易出现水泡等症状。如糖尿病患者发生烧伤烫伤或外伤,则非常容易发生综合性感染,各种细菌大量繁殖,特别是厌氧菌迅猛繁殖,感染速度加快,创面病情恶化,久治不愈,直至疽坏,最后只有截肢,其中85%是因小面积溃疡的治疗和处理不当造成的。到目前为止,国内外尚未总结出糖尿病足的有效治疗技术方案和手段。现在,西医主要运用抗生素抗感染,采用药物、手术、局部清创、新型外敷材料、干细胞移植、高压氧等手段,但是由于这些药有的价格偏高患者长期服用经济负担重,难以坚持;有的短期内有效,但存在易复发、疗效低的缺点。
发明内容
本发明要解决的技术问题是克服上述技术的缺陷,提供一种用于治疗糖尿病并发症的药物。
为解决上述技术问题,本发明提供的技术方案为一种用于治疗糖尿病并发症的药物,包括以下重量份的原料组成:血竭1-5份、三七1-3份、地榆1-2份、黄柏1-2份、野兔毛90-110份。
进一步地,包括以下重量份的原料组成:血竭1份、三七1份、地榆1份、黄柏1份、野兔毛90份。
进一步地,包括以下重量份的原料组成:血竭2份、三七2、地榆1份、黄柏1份、野兔毛100份。
进一步地,包括以下重量份的原料组成:血竭5份、三七3份、地榆2份、黄柏2份、野兔毛110份。
进一步地,所述药物的制备方法,包括以下步骤:
步骤1)先将野兔毛清洗干净,并放置于5%的84消毒液中浸泡消毒12h,然后烘干、紫外线消毒后,备用;
步骤2)按重量份取用血竭、三七、地榆、黄柏,粉碎后加清水1000ml熬煮2.5h,过滤,取其滤液,备用;
步骤3)将步骤1所制得的野兔毛,放入步骤2所得滤液中,浸泡4.5h,可得成品,即浸泡后野兔毛。
本发明所用原料来源如下:
血竭:甘咸,平;入心、肝、脾经;活血散瘀,定痛,止血生肌,敛疮;治跌打肿痛,内伤瘀痛;外伤出血不止,瘰疬,臁疮溃久不合。
三七:性温,味甘、微苦;归肝经、胃经;散瘀止血、消肿定痛;外用磨汁涂、研末撒或调敷患处。用治咯血、吐血、衄血、便血、崩漏、外伤出血、胸腹刺痛、跌扑肿痛。
地榆:性微寒,味苦、酸、涩;归肝经、大肠经;凉血止血、解毒敛疮;外用适量,研末涂敷患处。用治便血、痔血、血痢、崩漏、水火烫伤、痈肿疮毒。
黄柏:苦,寒;归肾、膀胱经;清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。
本发明与现有技术相比的优点在于:本发明所提供的药物配方设计合理,通过将野兔毛浸泡于血竭、三七、地榆、黄柏的浸泡液中,可制得所述药物;所制备的药物为敷料,使用方法为外敷,使用方便,且无任何毒副作用,所述药物适用于糖尿病足、老烂腿、褥疮、烫伤等病症,其疗效显著,见效较快。
具体实施方式
下面结合实施例对本发明一种用于治疗糖尿病并发症的药物做进一步的详细说明。
实施例1
一种用于治疗糖尿病并发症的药物,包括以下重量份的原料组成:血竭1份、三七1份、地榆1份、黄柏1份、野兔毛90份;
所述药物的制备包括以下步骤:
步骤1)先将野兔毛清洗干净,并放置于5%的84消毒液中浸泡消毒12h,然后烘干、紫外线消毒后,备用;
步骤2)按重量份取用血竭、三七、地榆、黄柏,粉碎后加清水1000ml熬煮2.5h,过滤,取其滤液,备用;
步骤3)将步骤1所制得的野兔毛,放入步骤2所得滤液中,浸泡4.5h,可得成品,即浸泡后野兔毛。
使用方法:先对患处进行清创消毒,然后取适量所得成品敷于患处,再用无菌纱布缠绕覆盖;
适用病症:糖尿病足,老烂腿,褥疮,烫伤;
治疗周期:七天一个疗程,其中创面较小的一个疗程可以痊愈,创面较大的需两个疗程痊愈。
实施例2
一种用于治疗糖尿病并发症的药物,包括以下重量份的原料组成:血竭2份、三七2、地榆1份、黄柏1份、野兔毛100份;
所述药物的制备包括以下步骤:
步骤1)先将野兔毛清洗干净,并放置于5%的84消毒液中浸泡消毒12h,然后烘干、紫外线消毒后,备用;
步骤2)按重量份取用血竭、三七、地榆、黄柏,粉碎后加清水1000ml熬煮2.5h,过滤,取其滤液,备用;
步骤3)将步骤1所制得的野兔毛,放入步骤2所得滤液中,浸泡4.5h,可得成品,即浸泡后野兔毛。
使用方法:先对患处进行清创消毒,然后取适量所得成品敷于患处,再用无菌纱布缠绕覆盖;
适用病症:糖尿病足,老烂腿,褥疮,烫伤;
治疗周期:七天一个疗程,其中创面较小的一个疗程可以痊愈,创面较大的需两个疗程痊愈。
实施例3
一种用于治疗糖尿病并发症的药物,包括以下重量份的原料组成:血竭5份、三七3份、地榆2份、黄柏2份、野兔毛110份;
所述药物的制备包括以下步骤:
步骤1)先将野兔毛清洗干净,并放置于5%的84消毒液中浸泡消毒12h,然后烘干、紫外线消毒后,备用;
步骤2)按重量份取用血竭、三七、地榆、黄柏,粉碎后加清水1000ml熬煮2.5h,过滤,取其滤液,备用;
步骤3)将步骤1所制得的野兔毛,放入步骤2所得滤液中,浸泡4.5h,可得成品,即浸泡后野兔毛。
使用方法:先对患处进行清创消毒,然后取适量所得成品敷于患处,再用无菌纱布缠绕覆盖;
适用病症:糖尿病足,老烂腿,褥疮,烫伤;
治疗周期:七天一个疗程,其中创面较小的一个疗程可以痊愈,创面较大的需两个疗程痊愈。
以上对本发明及其实施方式进行了描述,这种描述没有限制性。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (5)
1.一种用于治疗糖尿病并发症的药物,其特征在于,包括以下重量份的原料组成:血竭1-5份、三七1-3份、地榆1-2份、黄柏1-2份、野兔毛90-110份。
2.根据权利要求1所述的一种用于治疗糖尿病并发症的药物,其特征在于,包括以下重量份的原料组成:血竭1份、三七1份、地榆1份、黄柏1份、野兔毛90份。
3.根据权利要求1所述的一种用于治疗糖尿病并发症的药物,其特征在于,包括以下重量份的原料组成:血竭2份、三七2、地榆1份、黄柏1份、野兔毛100份。
4.根据权利要求1所述的一种用于治疗糖尿病并发症的药物,其特征在于,包括以下重量份的原料组成:血竭5份、三七3份、地榆2份、黄柏2份、野兔毛110份。
5.根据权利要求1至4任意一项所述的一种用于治疗糖尿病并发症的药物,其特征在于,所述药物的制备方法,包括以下步骤:
步骤1)先将野兔毛清洗干净,并放置于5%的84消毒液中浸泡消毒12h,然后烘干、紫外线消毒后,备用;
步骤2)按重量份取用血竭、三七、地榆、黄柏,粉碎后加清水1000ml熬煮2.5h,过滤,取其滤液,备用;
步骤3)将步骤1所制得的野兔毛,放入步骤2所得滤液中,浸泡4.5h,可得成品,即浸泡后野兔毛。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210483191.6A CN114796371A (zh) | 2022-05-05 | 2022-05-05 | 一种用于治疗糖尿病并发症的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210483191.6A CN114796371A (zh) | 2022-05-05 | 2022-05-05 | 一种用于治疗糖尿病并发症的药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114796371A true CN114796371A (zh) | 2022-07-29 |
Family
ID=82511487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210483191.6A Pending CN114796371A (zh) | 2022-05-05 | 2022-05-05 | 一种用于治疗糖尿病并发症的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114796371A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079669A (zh) * | 1993-04-17 | 1993-12-22 | 靳四贤 | 烧烫伤药的配制方法 |
CN101884694A (zh) * | 2009-05-14 | 2010-11-17 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病足的中药 |
CN102949499A (zh) * | 2011-08-22 | 2013-03-06 | 天津尖峰弗兰德医药科技发展有限公司 | 一种用于烫伤的中药组合物及制备方法 |
-
2022
- 2022-05-05 CN CN202210483191.6A patent/CN114796371A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079669A (zh) * | 1993-04-17 | 1993-12-22 | 靳四贤 | 烧烫伤药的配制方法 |
CN101884694A (zh) * | 2009-05-14 | 2010-11-17 | 北京绿源求证科技发展有限责任公司 | 一种治疗糖尿病足的中药 |
CN102949499A (zh) * | 2011-08-22 | 2013-03-06 | 天津尖峰弗兰德医药科技发展有限公司 | 一种用于烫伤的中药组合物及制备方法 |
Non-Patent Citations (2)
Title |
---|
周巨伦: "丹参注射液合愈溃散内外同治糖尿病足坏疽35例" * |
黄煌, 中国中医药出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103230493B (zh) | 一种治疗创口不愈的中药组合物 | |
CN106728727A (zh) | 一种治疗疮疡的药膏及其制备方法 | |
CN101164574B (zh) | 一种治疗烧伤烫伤的药物及其制备方法 | |
CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
CN101703651A (zh) | 一种治疗糖尿病坏疽的药物 | |
CN106138569B (zh) | 一种治疗慢性创面的中药组合及其应用 | |
CN114796371A (zh) | 一种用于治疗糖尿病并发症的药物 | |
CN114470056A (zh) | 一种治疗下肢静脉性溃疡的中药溻渍制剂组方及其制备和使用方法 | |
CN103655854B (zh) | 治疗静脉输液致静脉炎的外敷药及使用方法 | |
CN209172659U (zh) | 一种中药冷敷用膝关节康复器具 | |
CN111544514A (zh) | 一种用于治疗烧烫伤的中药膏剂及其制备方法 | |
CN107625848A (zh) | 一种治疗糖尿病足病的外用药剂及其制备方法 | |
CN109646512A (zh) | 一种用于促进慢性难愈性创面愈合的外用中药组合物 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN110403995B (zh) | 治疗浅静脉炎作用的中药组合物及制备、使用方法和应用 | |
CN111939203B (zh) | 一种治疗糖尿病足中药软膏制剂及其制备方法 | |
CN107496567A (zh) | 一种治疗糖尿病足病的中药制剂及其制备方法 | |
CN1075730C (zh) | 祛风通络拔毒散 | |
CN102526382A (zh) | 一种消肿止痛的膏药 | |
CN106362077B (zh) | 一种治疗烧烫伤及皮外伤的中药及其制作方法 | |
CN114010669A (zh) | 一种祛腐生肌软膏及其制备方法和应用 | |
CN105832909A (zh) | 一种治疗皮肤坏死性溃疡的中药制剂 | |
CN1243558C (zh) | 治疗骨疽的外用药物及其制备方法 | |
CN115444881A (zh) | 一种治疗外伤肿痛痛风性关节炎和皮肤感染的中药药膏 | |
CN117427120A (zh) | 一种溃疡治疗药膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220729 |